Table 1.
The demographic characteristics of the patients with PID and SID, and the control group.
| Control | PID | SID | p | ||||
|---|---|---|---|---|---|---|---|
| Mean±SD | Median (min-max) | Mean±SD | Median (min-max) | Mean±SD | Median (min-max) | ||
| Age (Month) | 65.46±63.71 | 42 (1-204) | 98.87±66.37 | 84 (7-216) | 67.89±40.19 | 57 (3-204) | 0.001 |
| Age at first hospitalization (Month) | 19.30±23.29 | 12.0 (1-120) | 14.62±26.66 | 3.0 (1-162) | 7.87 ±13.80 | 2.0 (1-60) | 0.001 |
| Age at diagnosis of immunodeficiency (Month) | 48.58±53.74 | 21.00 (1-192) | 36.64±38.87 | 24.00 (2-174) | 0.127 | ||
| Duration of diagnostic delay (Month) | 21.04±32.71 | 10.50 (1-186) | 21.67±25.79 | 12.0 (1-108) | 0.897 | ||
| Age at initiation of treatment (Month) | 55.06±58.36 | 27.00 (1-210) | 37.73±38.92 | 24.00 (2-174) | 0.025 | ||
| Duration of treatment (Month) | 39.22±32.42 | 30.00 (1-162) | 28.89±21.03 | 24.00 (1-120) | 0.015 | ||
| Age at discontinuation of treatment (Month) | 97.50±60.57 | 84.00 (36-204) | 39.00±4.24 | 39.00 (36-42) | 0.228 | ||
| Duration of follow-up (Month) | 49.57±41.76 | 36.00 (5-192) | 34.00±22.95 | 30.00 (1-120) | 0.007 | ||
PID, primary immunodeficieny; SID, secondary immunodeficiency.